Integrated analysis of transcriptomic and proteomic alterations in mouse models of ALS/FTD identify early metabolic adaptions with similarities to mitochondrial dysfunction disorders

References

• Neumann M. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences. Rev Neurol. 2013;169:793–8.
   PubMedGoogle Scholar
• Ling S-C, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416–38.
   PubMed Web of Science ®Google Scholar
• van Blitterswijk M, DeJesus-Hernandez M, Rademakers R. How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders? Curr Opin Neurol. 2012; 25:689–700.
   PubMed Web of Science ®Google Scholar
• Guerrero EN, Wang H, Mitra J, Hegde PM, Stowell SE, Liachko NF, et al. TDP-43/FUS in motor neuron disease: complexity and challenges. Prog Neurobiol. 2016;145–146:78–97.
   PubMed Web of Science ®Google Scholar
• Hedl TJ, San Gil R, Cheng F, Rayner SL, Davidson JM, De Luca A, et al. Proteomics approaches for biomarker and drug target discovery in ALS and FTD. Front Neurosci. 2019;13:548.
   PubMed Web of Science ®Google Scholar
• Deng J, Wang P, Chen X, Cheng H, Liu J, Fushimi K, et al. FUS interacts with ATP synthase beta subunit and induces mitochondrial unfolded protein response in cellular and animal models. Proc Natl Acad Sci U S A. 2018;115:E9678–E9686.
   PubMed Web of Science ®Google Scholar
• Wang W, Li L, Lin W-L, Dickson DW, Petrucelli L, Zhang T, et al. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum Mol Genet. 2013;22:4706–19.
   PubMed Web of Science ®Google Scholar
• Wang W, Wang L, Lu J, Siedlak SL, Fujioka H, Liang J, et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat Med. 2016; 22:869–78.
   PubMed Web of Science ®Google Scholar
• Tsai Y-L, Coady TH, Lu L, Zheng D, Alland I, Tian B, et al. ALS/FTD-associated protein FUS induces mitochondrial dysfunction by preferentially sequestering respiratory chain complex mRNAs. Genes Dev. 2020; 34:785–805.
   PubMed Web of Science ®Google Scholar
• Lee S, Kim S, Kang H-Y, Lim HR, Kwon Y, Jo M, et al. The overexpression of TDP-43 in astrocytes causes neurodegeneration via a PTP1B-mediated inflammatory response. J Neuroinflammation. 2020; 17:299. Available from: https://doi.org/10.1186/s12974-020-01963-6
   PubMed Web of Science ®Google Scholar
• Baek M, Choe Y-J, Bannwarth S, Kim J, Maitra S, Dorn GW, et al. TDP-43 and PINK1 mediate CHCHD10S59L mutation–induced defects in Drosophila and in vitro. Nat Commun. 2021;12:1924.
   PubMed Web of Science ®Google Scholar
• Kawamata H, Peixoto P, Konrad C, Palomo G, Bredvik K, Gerges M, et al. Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo. Mol Neurodegener. 2017;12:37.
   PubMed Web of Science ®Google Scholar
• Davis SA, Itaman S, Khalid-Janney CM, Sherard JA, Dowell JA, Cairns NJ, et al. TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics. Neurosci Lett. 2018; 678:8–15.
   PubMed Web of Science ®Google Scholar
• Onesto E, Colombrita C, Gumina V, Borghi MO, Dusi S, Doretti A, et al. Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts. Acta Neuropathol Commun. 2016; 4:47.
   PubMed Web of Science ®Google Scholar
• Vandoorne T, Veys K, Guo W, Sicart A, Vints K, Swijsen A, et al. Differentiation but not ALS mutations in FUS rewires motor neuron metabolism. Nat Commun. 2019;10:4147.
   PubMed Web of Science ®Google Scholar
• Shelkovnikova TA, Peters OM, Deykin AV, Connor-Robson N, Robinson H, Ustyugov AA, et al. Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice. J Biol Chem. 2013;288:25266–74.
   PubMed Web of Science ®Google Scholar
• Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A. 2009; 106:18809–14.
   PubMed Web of Science ®Google Scholar
• Coughlan KS, Halang L, Woods I, Prehn JHM. A high-fat jelly diet restores bioenergetic balance and extends lifespan in the presence of motor dysfunction and lumbar spinal cord motor neuron loss in TDP-43A315T mutant C57BL6/J mice. Dis Model Mech. 2016; 9:1029–37.
   PubMed Web of Science ®Google Scholar
• Hogg MC, Halang L, Woods I, Coughlan KS, Prehn JHM. Riluzole does not improve lifespan or motor function in three ALS mouse models. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:438–45.
   PubMed Web of Science ®Google Scholar
• Funikov SY, Rezvykh AP, Mazin PV, Morozov AV, Maltsev AV, Chicheva MM, et al. FUS(1-359) transgenic mice as a model of ALS: pathophysiological and molecular aspects of the proteinopathy. Neurogenetics. 2018; 19:189–204.
   PubMed Web of Science ®Google Scholar
• Ludolph AC, Bendotti C, Blaugrund E, Chio A, Greensmith L, Loeffler J-P, et al. Guidelines for preclinical animal research in ALS/MND: a consensus meeting. Amyotroph Lateral Scler. 2010;11:38–45.
   PubMed Web of Science ®Google Scholar
• Wischhof L, Gioran A, Sonntag-Bensch D, Piazzesi A, Stork M, Nicotera P, et al. A disease-associated Aifm1 variant induces severe myopathy in knockin mice. Mol Metab. 2018;13:10–23.
   PubMed Web of Science ®Google Scholar
• Lucantoni F, Salvucci M, Düssmann H, Lindner AU, Lambrechts D, Prehn JHM. BCL(X)L and BCL2 increase the metabolic fitness of breast cancer cells: a single-cell imaging study. Cell Death Differ. 2021; 28:1512–31.
   PubMed Web of Science ®Google Scholar
• Farrell J, Kelly C, Rauch J, Kida K, García-Muñoz A, Monsefi N, et al. HGF induces epithelial-to-mesenchymal transition by modulating the mammalian hippo/MST2 and ISG15 pathways. J Proteome Res. 2014;13:2874–86.
   PubMed Web of Science ®Google Scholar
• Ni M-W, Wang L, Chen W, Mou H-Z, Zhou J, Zheng Z-G. Modified filter-aided sample preparation (FASP) method increases peptide and protein identifications for shotgun proteomics. Rapid Commun Mass Spectrom. 2017;31:171–8.
   PubMed Web of Science ®Google Scholar
• Wiśniewski JR, Zougman A, Mann M. Combination of FASP and stagetip-based fractionation allows in-depth analysis of the hippocampal membrane proteome. J Proteome Res. 2009;8:5674–8.
   PubMed Web of Science ®Google Scholar
• Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21.
   PubMed Web of Science ®Google Scholar
• Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25:2078–9.
   PubMed Web of Science ®Google Scholar
• Anders S, Pyl PT, Huber W. HTSeq–a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31:166–9.
   PubMed Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139–40.
   PubMed Web of Science ®Google Scholar
• Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016;13:731–40.
   PubMed Web of Science ®Google Scholar
• Krey JF, Wilmarth PA, Shin J-B, Klimek J, Sherman NE, Jeffery ED, et al. Accurate label-free protein quantitation with high- and low-resolution mass spectrometers. J Proteome Res. 2014;13:1034–44.
   PubMed Web of Science ®Google Scholar
• Krey JF, Scheffer DI, Choi D, Reddy A, David LL, Corey DP, et al. Mass spectrometry quantitation of proteins from small pools of developing auditory and vestibular cells. Sci Data. 2018;5:180128.
   PubMed Web of Science ®Google Scholar
• R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria; 2013.
   Google Scholar
• Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47–e47.
   PubMed Web of Science ®Google Scholar
• Smyth GK, Michaud J, Scott HS. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics. 2005;21:2067–75.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012; 16:284–7.
   PubMed Web of Science ®Google Scholar
• Alexa A, Rahnenführer J, Lengauer T. Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics. 2006;22:1600–7.
   PubMed Web of Science ®Google Scholar
• Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature 2010;463:318–25.
   PubMed Web of Science ®Google Scholar
• Lefebvre C, Rajbhandari P, Alvarez MJ, Bandaru P, Lim WK, Sato M, et al. A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers. Mol Syst Biol. 2010;6:377.
   PubMed Web of Science ®Google Scholar
• Ikiz B, Alvarez MJ, Ré DB, Le Verche V, Politi K, Lotti F, et al. The regulatory machinery of neurodegeneration in in vitro models of amyotrophic lateral sclerosis. Cell Rep. 2015;12:335–45.
   PubMed Web of Science ®Google Scholar
• Brichta L, Shin W, Jackson-Lewis V, Blesa J, Yap E-L, Walker Z, et al. Identification of neurodegenerative factors using translatome-regulatory network analysis. Nat Neurosci. 2015;18:1325–33.
   PubMed Web of Science ®Google Scholar
• Khan A, Fornes O, Stigliani A, Gheorghe M, Castro-Mondragon JA, van der Lee R, et al. JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework. Nucleic Acids Res. 2018;46:D260–D266.
   PubMed Web of Science ®Google Scholar
• Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90–W97.
   PubMed Web of Science ®Google Scholar
• Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128.
   PubMed Web of Science ®Google Scholar
• Keenan AB, Torre D, Lachmann A, Leong AK, Wojciechowicz ML, Utti V, et al. ChEA3: transcription factor enrichment analysis by orthogonal omics integration. Nucleic Acids Res. 2019;47:W212–W224.
   PubMed Web of Science ®Google Scholar
• Menden K, Marouf M, Oller S, Dalmia A, Magruder DS, Kloiber K, et al. Deep learning-based cell composition analysis from tissue expression profiles. Sci Adv. 2020;6:eaba2619.
   PubMed Web of Science ®Google Scholar
• Kwong LK, Neumann M, Sampathu DM, Lee VM-Y, Trojanowski JQ. TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease. Acta Neuropathol. 2007;114:63–70.
   PubMed Web of Science ®Google Scholar
• Crivello M, Hogg MC, Jirström E, Halang L, Woods I, Rayner M, et al. Vascular regression precedes motor neuron loss in the FUS (1-359) ALS mouse model. Dis Model Mech. 2019;12(8).
   Google Scholar
• Vahsen N, Candé C, Brière J-J, Bénit P, Joza N, Larochette N, et al. AIF deficiency compromises oxidative phosphorylation. Embo J. 2004;23:4679–89.
   PubMed Web of Science ®Google Scholar
• Vafai SB, Mootha VK. Mitochondrial disorders as windows into an ancient organelle. Nature 2012;491:374–83.
   PubMed Web of Science ®Google Scholar
• Zeviani M, Di Donato S. Mitochondrial disorders. Brain. 2004;127:2153–72.
   PubMed Web of Science ®Google Scholar
• DiMauro S, Schon EA, Carelli V, Hirano M. The clinical maze of mitochondrial neurology. Nat Rev Neurol. 2013;9:429–44.
   PubMed Web of Science ®Google Scholar
• Koopman WJH, Distelmaier F, Smeitink JAM, Willems PHGM. OXPHOS mutations and neurodegeneration. Embo J. 2013;32(1):9–29.
   PubMed Web of Science ®Google Scholar
• Koopman WJH, Willems PHGM, Smeitink JAM. Monogenic mitochondrial disorders. N Engl J Med. 2012;366:1132–41.
   PubMed Web of Science ®Google Scholar
• El Ghouzzi V, Csaba Z, Olivier P, Lelouvier B, Schwendimann L, Dournaud P, et al. Apoptosis-inducing factor deficiency induces early mitochondrial degeneration in brain followed by progressive multifocal neuropathology. J Neuropathol Exp Neurol. 2007; 66:838–47.
   PubMed Web of Science ®Google Scholar
• Bénit P, Pelhaître A, Saunier E, Bortoli S, Coulibaly A, Rak M, et al. Paradoxical inhibition of glycolysis by pioglitazone opposes the mitochondriopathy caused by AIF deficiency. EBioMedicine 2017;17:75–87.
   PubMed Web of Science ®Google Scholar
• Bénit P, Goncalves S, Dassa EP, Brière J-J, Rustin P. The variability of the harlequin mouse phenotype resembles that of human mitochondrial-complex I-deficiency syndromes. PLOS One. 2008;3:e3208.
   PubMed Web of Science ®Google Scholar
• Hintze M, Griesing S, Michels M, Blanck B, Wischhof L, Hartmann D, et al. Alopecia in Harlequin mutant mice is associated with reduced AIF protein levels and expression of retroviral elements. Mamm Genome. 2021;32:12–29.
   PubMed Web of Science ®Google Scholar
• Klein JA, Longo-Guess CM, Rossmann MP, Seburn KL, Hurd RE, Frankel WN, et al. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 2002;419:367–74.
   PubMed Web of Science ®Google Scholar
• Pascovici D, Handler DCL, Wu JX, Haynes PA. Multiple testing corrections in quantitative proteomics: a useful but blunt tool. Proteomics 2016;16:2448–53.
   PubMed Web of Science ®Google Scholar
• Coady TH, Manley JL. ALS mutations in TLS/FUS disrupt target gene expression. Genes Dev. 2015;29:1696–706.
   PubMed Web of Science ®Google Scholar
• Padanad MS, Konstantinidou G, Venkateswaran N, Melegari M, Rindhe S, Mitsche M, et al. Fatty acid oxidation mediated by Acyl-CoA synthetase long chain 3 is required for mutant KRAS lung tumorigenesis. Cell Rep. 2016; 16:1614–28.
   PubMed Web of Science ®Google Scholar
• Fujimoto Y, Itabe H, Kinoshita T, Homma KJ, Onoduka J, Mori M, et al. Involvement of ACSL in local synthesis of neutral lipids in cytoplasmic lipid droplets in human hepatocyte HuH7. J Lipid Res. 2007; 48:1280–92.
   PubMed Web of Science ®Google Scholar
• Pennetta G, Welte MA. Emerging links between lipid droplets and motor neuron diseases. Dev Cell. 2018;45:427–32.
   PubMed Web of Science ®Google Scholar
• Fujino T, Kang M-J, Suzuki H, Iijima H, Yamamoto T. Molecular characterization and expression of rat acyl-CoA synthetase 3. J Biol Chem. 1996;271:16748–52.
   PubMed Web of Science ®Google Scholar
• Zeidán-Chuliá F, de Oliveira B-HN, Salmina AB, Casanova MF, Gelain DP, Noda M, et al. Altered expression of Alzheimer’s disease-related genes in the cerebellum of autistic patients: a model for disrupted brain connectome and therapy. Cell Death Dis. 2014;5(5):e1250–e1250.
   PubMed Web of Science ®Google Scholar
• Alston CL, Heidler J, Dibley MG, Kremer LS, Taylor LS, Fratter C, et al. Bi-allelic mutations in NDUFA6 establish its role in early-onset isolated mitochondrial complex I deficiency. Am J Hum Genet. 2018;103:592–601.
   PubMed Web of Science ®Google Scholar
• Murray J, Taylor SW, Zhang B, Ghosh SS, Capaldi RA. Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry. J Biol Chem. 2003;278:37223–30.
   PubMed Web of Science ®Google Scholar
• Grünewald A, Rygiel KA, Hepplewhite PD, Morris CM, Picard M, Turnbull DM. Mitochondrial DNA depletion in respiratory chain-deficient parkinson disease neurons. Ann Neurol. 2016;79:366–78.
   PubMed Web of Science ®Google Scholar
• Adav SS, Park JE, Sze SK. Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer’s disease. Mol Brain. 2019; Jan12:8.
   PubMed Web of Science ®Google Scholar
• Napoli E, Wong S, Hung C, Ross-Inta C, Bomdica P, Giulivi C. Defective mitochondrial disulfide relay system, altered mitochondrial morphology and function in Huntington’s disease. Hum Mol Genet. 2013;22:989–1004.
   PubMed Web of Science ®Google Scholar
• Borowski LS, Dziembowski A, Hejnowicz MS, Stepien PP, Szczesny RJ. Human mitochondrial RNA decay mediated by PNPase-hSuv3 complex takes place in distinct foci. Nucleic Acids Res. 2013;41:1223–40.
   PubMed Web of Science ®Google Scholar
• Riley LG, Cooper S, Hickey P, Rudinger-Thirion J, McKenzie M, Compton A, et al. Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia–MLASA syndrome. Am J Hum Genet. 2010;87:52–9.
   PubMed Web of Science ®Google Scholar
• Riley LG, Heeney MM, Rudinger-Thirion J, Frugier M, Campagna DR, Zhou R, et al. The phenotypic spectrum of germline YARS2 variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2. Haematologica 2018;103:2008–15.
   PubMed Web of Science ®Google Scholar
• Shahni R, Wedatilake Y, Cleary MA, Lindley KJ, Sibson KR, Rahman S. A distinct mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) phenotype associates with YARS2 mutations. Am J Med Genet. 2013;161:A2334–8.
   Web of Science ®Google Scholar
• Riley LG, Menezes MJ, Rudinger-Thirion J, Duff R, de Lonlay P, Rotig A, et al. Phenotypic variability and identification of novel YARS2 mutations in YARS2 mitochondrial myopathy, lactic acidosis and sideroblastic anaemia. Orphanet J Rare Dis. 2013;8:193.
   PubMed Web of Science ®Google Scholar
• Sommerville EW, Ng YS, Alston CL, Dallabona C, Gilberti M, He L, et al. Clinical features, molecular heterogeneity, and prognostic implications in YARS2-related mitochondrial myopathy. JAMA Neurol. 2017; 74:686–94.
   PubMed Web of Science ®Google Scholar
• Meyer-Schuman R, Antonellis A. Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease. Hum Mol Genet. 2017; 26:R114–R127.
   PubMed Web of Science ®Google Scholar
• Dittmar KA, Goodenbour JM, Pan T. Tissue-specific differences in human transfer RNA expression. PLOS Genet. 2006; 2:e221.
   PubMed Web of Science ®Google Scholar
• Sansa A, Miralles MP, Beltran M, Celma-Nos F, Calderó J, Garcera A, et al. ERK MAPK signaling pathway inhibition as a potential target to prevent autophagy alterations in spinal muscular atrophy motoneurons. Cell Death Discov. 2023;9:113.
   PubMed Web of Science ®Google Scholar
• Watts ME, Wu C, Rubin LL. Suppression of MAP4K4 signaling ameliorates motor neuron degeneration in amyotrophic lateral sclerosis-molecular studies toward new therapeutics. J Exp Neurosci. 2019;13:1179069519862798.
   Web of Science ®Google Scholar
• Isopi E, Granzotto A, Corona C, Bomba M, Ciavardelli D, Curcio M, et al. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer’s disease without reducing amyloid and tau pathology. Neurobiol Dis. 2015;81:214–24.
   PubMed Web of Science ®Google Scholar
• Connolly NMC, Theurey P, Adam-Vizi V, Bazan NG, Bernardi P, Bolaños JP, et al. Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases. Cell Death Differ. 2018;25:542–72.
   PubMed Web of Science ®Google Scholar
• Saavedra-García P, Roman-Trufero M, Al-Sadah HA, Blighe K, López-Jiménez E, Christoforou M, et al. Systems level profiling of chemotherapy-induced stress resolution in cancer cells reveals druggable trade-offs. Proc Natl Acad Sci U S A 2021;118(17):e2018229118.
   PubMed Web of Science ®Google Scholar
• Bailey AP, Koster G, Guillermier C, Hirst EMA, MacRae JI, Lechene CP, et al. Antioxidant role for lipid droplets in a stem cell niche of Drosophila. Cell 2015;163:340–53.
   PubMed Web of Science ®Google Scholar
• Li N, Sancak Y, Frasor J, Atilla-Gokcumen GE. A protective role for triacylglycerols during apoptosis. Biochemistry [Internet]. 2018; 57:72–80. Available from: https://doi.org/10.1021/acs.biochem.7b00975
   Google Scholar
• Liu L, Zhang K, Sandoval H, Yamamoto S, Jaiswal M, Sanz E, et al. Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell [Internet]. 2015; 160:177–90. Available from: https://linkinghub.elsevier.com/retrieve/pii/S009286741401589X
   Google Scholar
• Kassan A, Herms A, Fernández-Vidal A, Bosch M, Schieber NL, Reddy BJN, et al. Acyl-CoA synthetase 3 promotes lipid droplet biogenesis in ER microdomains. J Cell Biol. 2013;203:985–1001. Available from: https://rupress.org/jcb/article/203/6/985/37677/AcylCoA-synthetase-3-promotes-lipid-droplet
   PubMed Web of Science ®Google Scholar
• Sanhueza M, Chai A, Smith C, McCray BA, Simpson TI, Taylor JP, et al. Network analyses reveal novel aspects of ALS pathogenesis. PLOS Genet. 2015;11:e1005107.
   PubMed Web of Science ®Google Scholar
• de Aguilar J-LG, Dupuis L, Oudart H, Loeffler J-P. The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu/Zn-superoxide dismutase mice. Biomed Pharmacother. 2005;59:190–6.
   PubMed Web of Science ®Google Scholar
• Carreño-Gago L, Juárez-Flores DL, Grau JM, Ramón J, Lozano E, Vila-Julià F, et al. Two novel variants in YARS2 gene are responsible for an extended MLASA phenotype with pancreatic insufficiency. J Clin Med 2021; 10:3471. Available from: https://www.mdpi.com/2077-0383/10/16/3471
   PubMed Web of Science ®Google Scholar
• Jin X, Zhang Z, Nie Z, Wang C, Meng F, Yi Q, et al. An animal model for mitochondrial tyrosyl-tRNA synthetase deficiency reveals links between oxidative phosphorylation and retinal function. J Biol Chem. 2021; 296:100437.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44:D457–D462.
   PubMed Web of Science ®Google Scholar